20.03.2014 • News

Lanxess Sells Perlon Monofil Business to Serafin Group

Troubled German specialty chemicals producer Lanxess has sold its wholly owned subsdiary Perlon-Monofil to Germany's Serafin Group for an undisclosed sum.

The divestment had been anticipated after the company last September said it was studying "strategic options" for certain non-core businesses.

Perlon-Monofil, one of the activities Lanxess inherited in its spin-off from Bayer in 2004, is a global market leader for polyamide and polyester (PET) monofil products sold under the trade names Perlon, Atlas and Bayco.

The company with 100 employees and sales of €30 million operates a production facility and technical center at Dormagen, Germany.

Through its Nextrusion unit based near Augsburg, Germany, Serafin already has good standing within the PET monofilaments for paper machine clothing and other technical textiles, said Lanxess board member Werner Breuers.

The acquisition will strengthen the market position both of Perlon-Monofil and Nextrusion, said Serafin managing director Philipp Haindl.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

From Catalogue to Collaboration

Enamine's Expert Insights Collection Is Free to Download
Enamine’s 35 Years of Advancing Drug Discovery

Enamine's Expert Insights Collection Is Free to Download

From catalogue to collaboration — explore 35 years of drug discovery breakthroughs, novel building blocks, and the science shaping tomorrow's medicines. Download your complimentary copy now.

most read